Tiscali Quicklinks. Please visit our Accessibility Page for a list of the Access Keys you can use to find your way around the site, skip directly to the main navigation, to the page content, or to more links within lifestyle.
- Disturbances of the gut such as diarrhoea, flatulence, nausea, vomiting or abdominal pain.
- Headache.
- Fatigue.
- Balance problems involving the inner ear (vertigo).
- Skin reactions such as rash and itch.
- Abnormal reaction of the skin to light, usually a rash, redness or blistering (photosensitivity).
- Inflammation of the pancreas (pancreatitis).
- Abnormal blood clot in a blood vessel, eg in the leg (deep vein thrombosis) or lungs (pulmonary embolism).
- Hair loss (alopecia).
- Sexual problems.
- Alteration in results of liver function tests.
- Gallstones.
- Muscle pain, inflammation, cramps or weakness.
- Muscle breakdown (rhabdomyolysis).
- Inflammation of the liver (hepatitis).
The side effects listed above may not include all of the side effects reported by the drug's manufacturer.
How can this medicine affect other medicines?
It is important to tell your doctor or pharmacist what medicines you are already taking, including those bought without a prescription and herbal medicines, before you start treatment with this medicine. Similarly, check with your doctor or pharmacist before taking any new medicines while taking this one, to ensure that the combination is safe.
There is an increased risk of side effects on the muscles (myopathy) if fenofibrate is taken in combination with other fibrate medicines, or statins used for lowering cholesterol such as simvastatin. These should be used with caution with fenofibrate. If you are taking another fibrate or a statin in combination with this medicine you should inform your doctor immediately if you experience any muscular symptoms (see warning above).
Fenofibrate increases the anti-blood-clotting effect of anticoagulant medicines such as warfarin, thus increasing the risk of bleeding. For this reason, if you are taking an anticoagulant medicine your doctor may need to decrease your dose when you start taking fenofibrate as well. Your blood clotting time (INR) should be regularly monitored so that your anticoagulant dose can be adjusted as necessary.
If you take fenofibrate in combination with the immunosuppressant medicine ciclosporin, there may be a risk of a decline in your kidney function. For this reason, people taking both these medicines should have their kidney function closely monitored.
Fenofibrate may enhance the blood sugar lowering effects of insulin and sulphonylurea medicines for diabetes, such as glibenclamide or gliclazide. If you are taking one of these medicines to control diabetes, you should be aware that fenofibrate may cause unpredictable drops in your blood sugar and your doctor may need to reduce your dose of antidiabetic medicine.
Other medicines containing the same active ingredient
| Lipantil micro | Supralip |
<<Go To Page 1
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care or attention by a qualified practitioner. The materials in this web site cannot and should not be used as a basis for diagnosis or choice of treatment. Conditions for use
![]()
© Copyright 1998 - 2004 NetDoctor.co.uk - All rights reserved